Aller au contenu principal
Profil bibliographique

Luigi Albanese

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

4Publications signalées
18Citations signalées
0Affiliations récentes

Les domaines associés

Blood Pressure and Hypertension StudiesHeart Failure Treatment and ManagementDialysis and Renal Disease ManagementDiabetes Treatment and ManagementRenin-Angiotensin System Studies

Les publications récentes

Accès ouvert 2022 article OpenAlex

Possible effect of dialysis membrane in polymethylmethacrylate on clinical variables associated with atherosclerosis development in chronic renal failure patients

Patrizio Imperiali, Chiara Ralli, Diletta Duranti, Clienti Carla et autres

Background: Chronic hemodialysis patients have higher cardiovascular morbidity compared to the general population. A number of studies have suggested that patients undergoing hemodialysis with polymethylmethacrylate (PMMA) membranes have a better outcome compared to other membranes. Methods: We performed a retrospective, multicenter study …

0 citations Archives of Renal Diseases and Management
Accès ouvert 2013 conference-paper OpenAlex

The role of dyes extracted from plants in protecting natural fabrics

L. Bacci, Francesca Camilli, D. Grifoni, Luigi Albanese et autres

The safest protection from UV radiation (UVR) exposure is provided by clothing and depends on fabric composition (natural, artificial or synthetic fibers) and parameters (porosity, weight and thickness), as well as dyeing methods and properties (natural or synthetic dyes, dye concentration, UV …

0 citations Florence Research (University of Florence)
2001 article OpenAlex

Irbesartan Effects on Renal Function in Patients with Renal Impairment and Hypertension: A Drug-Withdrawal Study

Maria Leonarda De Rosa, Alessandro de Cristofaro, Massimiliano Rossi, Antonio Baiano et autres

The blood-pressure lowering activity, tolerability, and safety of irbesartan was evaluated in 52 hypertensive patients with chronic renal insufficiency. After a 3-week placebo period, once-daily irbesartan was administered for 12 weeks at a daily dose of 150 mg titrated to 300 mg. …

it (code pays fourni par la source)

15 citations Journal of Cardiovascular Pharmacology

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.